Get the Stockscreener App
1.59
3.64%
-0.06
After Hours:
1.58
-0.01
-0.63%
Macrogenics Inc stock is traded at $1.59, with a volume of 490.82K.
It is down -3.64% in the last 24 hours and up +8.16% over the past month.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.
See More
Previous Close:
$1.65
Open:
$1.64
24h Volume:
490.82K
Relative Volume:
0.37
Market Cap:
$100.50M
Revenue:
$139.77M
Net Income/Loss:
$-97.62M
P/E Ratio:
-1.0063
EPS:
-1.58
Net Cash Flow:
$-61.71M
1W Performance:
-20.50%
1M Performance:
+8.16%
6M Performance:
-33.19%
1Y Performance:
-55.96%
1-Day Range:
$1.57
$1.64
1-Week Range:
$1.57
$1.97
52-Week Range:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
Name
Macrogenics Inc
Sector
Industry
Phone
301-251-5172
Address
9704 MEDICAL CENTER DRIVE, Rockville, MD
Compare MGNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.59 | 108.71M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-01-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-31-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-31-24 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| May-10-24 | Downgrade | Stifel | Buy → Hold |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| Apr-26-24 | Initiated | B. Riley Securities | Buy |
| Apr-09-24 | Upgrade | TD Cowen | Hold → Buy |
| Mar-04-24 | Reiterated | BTIG Research | Buy |
| Feb-14-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-20-23 | Upgrade | Citigroup | Neutral → Buy |
| Nov-07-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-22-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-14-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jul-18-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Jul-11-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| May-04-22 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-28-22 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Feb-04-22 | Initiated | SMBC Nikko | Outperform |
| Nov-17-21 | Resumed | Guggenheim | Buy |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Upgrade | Barclays | Underweight → Overweight |
| Dec-22-20 | Resumed | H.C. Wainwright | Buy |
| Aug-03-20 | Downgrade | Citigroup | Buy → Neutral |
| Jun-01-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-26-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Dec-19-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-21-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| May-03-19 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-12-19 | Initiated | Guggenheim | Neutral |
| Feb-07-19 | Upgrade | Citigroup | Sell → Buy |
| Feb-07-19 | Downgrade | Wedbush | Outperform → Neutral |
| Feb-06-19 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Feb-04-19 | Downgrade | Citigroup | Neutral → Sell |
| Dec-10-18 | Downgrade | Raymond James | Outperform → Underperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| May-31-18 | Initiated | Evercore ISI | Outperform |
| Mar-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-31-17 | Initiated | Raymond James | Outperform |
View All
Macrogenics Inc Stock (MGNX) Latest News
Nuveen LLC Makes New Investment in MacroGenics, Inc. $MGNX - MarketBeat
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances By Investing.com - Investing.com South Africa
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances - Investing.com India
Published on: 2025-09-08 14:52:02 - beatles.ru
MacroGenics Inc. Flashes Buy Signal on Multi Timeframe ChartJuly 2025 Earnings & Fast Entry Momentum Alerts - beatles.ru
Long term hold vs stop loss in MacroGenics Inc.Buy Signal & Accurate Buy Signal Notifications - Newser
Can MacroGenics Inc. reach all time highs this yearPortfolio Growth Summary & Technical Analysis for Trade Confirmation - خودرو بانک
What is MacroGenics Inc.’s market position2025 Growth vs Value & Short-Term Trading Alerts - خودرو بانک
What is the next catalyst for MacroGenics Inc.Portfolio Performance Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Top chart patterns to watch in MacroGenics Inc.Weekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Can MacroGenics Inc. stock double in the next yearEarnings Beat & Real-Time Volume Analysis - خودرو بانک
Will MacroGenics Inc. benefit from macro trendsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
MacroGenics' Strategic Divestitures and Implications for Biotech Innovation - AInvest
MacroGenics: Struggling Wheeler- Dealer Dealt Away Its Best Bets (NASDAQ:MGNX) - Seeking Alpha
Can MacroGenics Inc. recover in the next quarterLayoff News & Smart Swing Trading Techniques - Newser
What to do if you’re stuck in MacroGenics Inc.Market Activity Recap & AI Optimized Trade Strategies - Newser
Smart tools for monitoring MacroGenics Inc.’s price actionJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
Macrogenics, Inc. shares rise 2.58% premarket after Johnson & Johnson's Alzheimer research progress and AstraZeneca's successful drug trial. - AInvest
Measuring MacroGenics Inc.’s beta against major indices2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Key metrics from MacroGenics Inc.’s quarterly dataPortfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Using Ichimoku Cloud for MacroGenics Inc. technicalsPortfolio Return Report & Growth-Oriented Investment Plans - Newser
Strategies to average down on MacroGenics Inc.Weekly Volume Report & Free Reliable Trade Execution Plans - Newser
How to build a dashboard for MacroGenics Inc. stockMarket Activity Summary & Capital Efficiency Focused Strategies - Newser
How to build a custom watchlist for MacroGenics Inc.July 2025 Update & Weekly Stock Breakout Alerts - Newser
Is MacroGenics Inc. forming a bottoming base2025 Market Trends & Low Drawdown Investment Ideas - Newser
Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
News impact scoring models applied to MacroGenics Inc.Weekly Trend Recap & Low Risk Entry Point Guides - Newser
How to interpret RSI for MacroGenics Inc. stockInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Trend analysis for MacroGenics Inc. this week2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Pattern recognition hints at MacroGenics Inc. upsideBear Alert & Expert Curated Trade Setups - Newser
Trend Report: Can MacroGenics Inc. stock double in the next yearTrade Entry Summary & High Return Trade Guides - خودرو بانک
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
How liquid is MacroGenics Inc. stockJuly 2025 Movers & AI Powered Trade Plan Recommendations - خودرو بانک
Institutional scanner results for MacroGenics Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
What is MacroGenics Inc. s 5 year growth outlookQuarterly Market Summary & Expert Approved Momentum Trade Ideas - خودرو بانک
How to track smart money flows in MacroGenics Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Is MacroGenics Inc. stock heavily shortedJuly 2025 PreEarnings & Technical Entry and Exit Tips - خودرو بانک
Applying Elliott Wave Theory to MacroGenics Inc.2025 Technical Overview & Technical Pattern Alert System - Newser
Using fundamentals and technicals on MacroGenics Inc.2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Is MacroGenics Inc. exposed to political riskFed Meeting & Verified Momentum Stock Watchlist - خودرو بانک
Will MacroGenics Inc. benefit from AI trends2025 Buyback Activity & Expert Curated Trade Setups - خودرو بانک
Technical Charts Suggest Momentum Shift in MacroGenics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Macrogenics Inc Stock (MGNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):